BridgeMD
New treatment option for Knee Arthroplasty, Total
Official title Functional Impact at 12 Months Post-op of Posterior Cruciate Ligament Conservation During Robotic-assisted Surgery (MAKO) for Total Knee Replacement.
ClinicalTrials.gov ID: NCT07489963
What this study is testing
- What it's testing
- Studies have been made on the best way to do knee surgery and whether to conserve the posterior cruciate ligament or not during total knee prosthesis insertion is still under debate. However, most of these studies were made before the introduction of robotic knee surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient scheduled for first-intention robotic-assisted total knee replacement (MAKO).
- Unilateral replacement, regardless of laterality.
- Patient able to answer questionnaires.
- Patient willing to undergo usual 12-month follow-up.
- Patient has given free and informed consent and has signed the consent form.
You likely can't join if
- Patient with intraoperative technical impossibility of retaining PCL (flessum \> 20°, flexion stiffening \< 100°).
- Previous posterior cruciate ligament surgery.
- Post-traumatic gonarthrosis.
- Valgus \> 185°.
- Patient with septic complication.
- Patient participating in another treatment trial.
See the full eligibility criteria
- Patient scheduled for first-intention robotic-assisted total knee replacement (MAKO).
- Unilateral replacement, regardless of laterality.
- Patient able to answer questionnaires.
- Patient willing to undergo usual 12-month follow-up.
- Patient has given free and informed consent and has signed the consent form.
- Patient affiliated with or benefiting from a health insurance scheme.
- Patient with intraoperative technical impossibility of retaining PCL (flessum \> 20°, flexion stiffening \< 100°).
- Previous posterior cruciate ligament surgery.
- Post-traumatic gonarthrosis.
- Valgus \> 185°.
- Patient with septic complication.
- Patient participating in another treatment trial.
- Patient in an exclusion period determined by another study.
- Patient under court protection, guardianship or curatorship.
- Patient unable to give consent.
- Patients for whom it is impossible to provide informed information.
- Pregnant women
The study team makes the final eligibility decision.
Where it's taking place
- Bordeaux, France
- Lyon, France
- Nîmes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bordeaux, France; Lyon, France; Nîmes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.